DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old

BACKGROUND: The new combination of DTwP-HB-Hib vaccines has been developed in Indonesia following World Health Organization (WHO) recommendation and integrated into national immunization program. The aims of the study were to measure 1) antibody persistence 12–18 months after a primary series, 2) im...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunardi, Hartono, Rusmil, Kusnandi, Fadlyana, Eddy, Soedjatmiko, Dhamayanti, Meita, Sekartini, Rini, Tarigan, Rodman, Satari, Hindra Irawan, Medise, Bernie Endyarni, Sari, Rini Mulia, Bachtiar, Novilia Sjafri, Kartasasmita, Cissy B., Hadinegoro, Sri Rezeki S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971417/
https://www.ncbi.nlm.nih.gov/pubmed/29804542
http://dx.doi.org/10.1186/s12887-018-1143-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971417/
https://www.ncbi.nlm.nih.gov/pubmed/29804542
http://dx.doi.org/10.1186/s12887-018-1143-6

Ejemplares similares